3 articles published in Mevlana Tıp Bilimleri with the keyword "Mortalite": Interplay of Tocilizumab in Critical COVID-19 Cases; MORTALITY DATA OF OUR NEONATAL INTENSIVE CARE UNIT FOR 2010-2019; Investigation of Candida Species Isolated from Blood Cultures in Intensive Care Units
HİLAL AKAY ÇİZMECİOĞLU, MEVLÜT HAKAN GÖKTEPE, HALİL IBRAHİM BAYRAKTAR, AHMET ÇİZMECİOĞLU
Mevlana Tıp Bilimleri, 2023, Vol 3, Issue 2, Page 66-71
ABSTRACT Aim: Tocilizumab (TCZ) has become a prominent antibody-based therapeutic option among treatment regimens during the Corona Virus 2019 (COVID-19) pandemic. This study aimed to evaluate laboratory changes, prognostic laboratory biomarkers, and the effects of the timing of TCZ application on...
FATİH ERCAN, HÜSEYİN ALTUNHAN
Mevlana Tıp Bilimleri, 2023, Vol 3, Issue 1, Page 11-16
ABSTRACT Introduction: The neonatal period includes first 28 days of life. Infant and neonatal mortality rates are considered as a favorable indicator for measuring health status of a nation. In this study, we aimed to determine mortality rates, causes and risk factors of patients were admitted in...
ESRA ARAÇ, FATMA ESENKAYA TAŞBENT, METİN DOĞAN
Mevlana Tıp Bilimleri, 2021, Vol 1, Issue 2, Page 33-36
Aim: Invasive Candida infections are an increasing cause of mortality and morbidity, especially in patients being treated in intensive care patients. The delayed treatment of candidemia is an important determinant of patient progression. In this study, we aimed to determine the species distribution...
MortalityCOVID-19Hastalık şiddetiİnterlökin 6TosilizumabDisease severityInterleukin-6TocilizumabyenidoğanprematüritenewbornprematurityCandida TürleriKandidemiCandida SpeciesCandidemia
